Auteurs
Analysis
Allemagne
Racine
Analysis
Allemagne
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Kjell Asplund »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Kjeld Schmiegelow < Kjell Asplund < Kjell Grankvist  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
002963 (2000) Kennedy R. Lees [Royaume-Uni] ; Kjell Asplund [Suède] ; Antonio Carolei [Italie] ; Stephen M. Davis [Australie] ; Hans-Christoph Diener [Allemagne] ; Markku Kaste [Finlande] ; Jean-Marc Orgogozo [France] ; John Whitehead [Royaume-Uni]Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial

List of associated KwdEn.i

Nombre de
documents		Descripteur
1Acute ischaemic stroke
1Acute ischemic stroke
1Acute stroke
1Acute stroke treatment
1Acute stroke trials
1Adult
1Adverse events
1Animal models
1Antagonist
1Artery occlusion
1Barthel
1Barthel index
1Barthel index score
1Barthel index scores
1Barthel score
1Baseline
1Baseline severity
1Cerebrospinal fluid
1Chemotherapy
1Clinical trial
1Diener
1Double blind study
1Drug effect
1Elderly
1Endpoint
1Evolution
1Gain americas
1Gavestinel
1Gavestinel group
1Gavestinel placebo
1Glaxo wellcome
1Global efficacy
1Glutamate
1Glutamate antagonist
1Glycine
1Glycine antagonist
1Glycine site
1Haemorrhage
1Haemorrhagic stroke
1Hospital discharge
1Human beings
1Human stroke
1Infarct volume
1Interim analysis
1Intracerebral haemorrhage
1Intracranial haemorrhage
1Ischaemic
1Ischaemic patients
1Ischaemic stroke
1Ischaemic strokes
1John whitehead
1Kjell asplund
1Lancet
1Lees
1Liver function tests
1Loading dose
1Magnetic resonance imaging
1Markku kaste
1National institute
1Neurological disorders
1Neurological status
1Neuroprotective
1Neuroprotective agent
1Neuroprotective drugs
1Nihss
1Nmda
1Nmda receptor
1Odds ratio
1Patients randomised
1Placebo
1Placebo group
1Plasma concentration
1Primary analysis
1Primary efficacy analysis
1Primary efficacy population
1Primary endpoint
1Primary intracranial haemorrhage
1Primary outcome
1Primary outcome measure
1Randomised
1Rankin scale
1Rankin score
1Receptor
1Secondary analyses
1Secondary endpoints
1Selective antagonist
1Small proportion
1Stratification variables
1Stroke
1Stroke onset
1Stroke patients
1Stroke severity
1Study drug
1Study medication
1Target population
1Thrombolytic therapy
1Treatment
1Treatment efficiency
1Treatment groups
1Video training

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Kjell Asplund" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Kjell Asplund" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Kjell Asplund
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024